6-33164413-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_080680.3(COL11A2):c.4924C>G(p.Leu1642Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000188 in 1,599,192 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_080680.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL11A2 | NM_080680.3 | c.4924C>G | p.Leu1642Val | missense_variant | Exon 65 of 66 | ENST00000341947.7 | NP_542411.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL11A2 | ENST00000341947.7 | c.4924C>G | p.Leu1642Val | missense_variant | Exon 65 of 66 | 5 | NM_080680.3 | ENSP00000339915.2 | ||
COL11A2 | ENST00000374708.8 | c.4666C>G | p.Leu1556Val | missense_variant | Exon 63 of 64 | 5 | ENSP00000363840.4 | |||
COL11A2 | ENST00000477772.1 | n.714C>G | non_coding_transcript_exon_variant | Exon 8 of 9 | 2 | |||||
COL11A2 | ENST00000683572.1 | n.730C>G | non_coding_transcript_exon_variant | Exon 8 of 9 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000908 AC: 2AN: 220374Hom.: 0 AF XY: 0.00000831 AC XY: 1AN XY: 120320
GnomAD4 exome AF: 0.0000193 AC: 28AN: 1447028Hom.: 0 Cov.: 32 AF XY: 0.0000237 AC XY: 17AN XY: 718770
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74332
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1642 of the COL11A2 protein (p.Leu1642Val). This variant is present in population databases (rs770715075, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with COL11A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 517184). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt COL11A2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
The p.Leu1642Val variant in COL11A2 has not been previously reported in individu als with hearing loss or in large population studies, but has been identified in 2/28578 European chromosomes by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org; dbSNP rs770715075). Computational prediction tools and conservation analysis suggest that the p.Leu1642Val variant may impact the prote in, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Leu1642Val variant is uncertain. -
COL11A2-related disorder Uncertain:1
The COL11A2 c.4924C>G variant is predicted to result in the amino acid substitution p.Leu1642Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0021% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-33132190-G-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at